Meridian Bioscience, Inc. Reports Record Operating Results, Declares Regular Cash Dividend, Reaffirms Higher Fiscal 2006 Guidance, And Comments On Fiscal 2007 Outlook

CINCINNATI--(BUSINESS WIRE)--July 20, 2006--Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ:VIVO - News) today: reported record third quarter and nine-month sales of $26,583,000 and $79,763,000, respectively, an increase of 5% and 17% over the same periods of the prior fiscal year; reported record third quarter and nine-month operating income of $6,893,000 and $20,040,000, respectively, an increase of 21% and 39% over the same periods of the prior fiscal year.